We interpret this trend as evidence of BRD9-dependent regulation of the core AML circuitry, with strong overlap between BRD9 bromodomain-dependent accessible regions of chromatin and PU.1, CEBPa, and MYC, among others. Here, CEBPA is linked to acute myeloid leukemia.